Development of a new rutin nanoemulsion and its application on prostate carcinoma PC3 cell line

EXCLI Journal

Volumn 16, Issue , 2017, Pages 810-823

  Ahmad, Mohammad ^a   Sahabjada, ^b   Akhtar, Juber ^a   Hussain, Arshad ^a,c   Badaruddeen, ^a   Arshad, Md ^b   Mishra, Anuradha ^a  

^a INTEGRAL UNIVERSITY   (India)

^b UNIVERSITY OF LUCKNOW   (India)

^c KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

Cell viability; Nanoemulsion; Prostate cancer; Reactive oxygen species; Rutin; Water titration method

Indexed keywords

REACTIVE OXYGEN METABOLITE; RUTOSIDE; WATER;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISPERSITY; DRUG EFFICACY; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; MTT ASSAY; NANOEMULSION; PROSTATE CANCER CELL LINE; SURFACE PROPERTY; ZETA POTENTIAL;

EID: 85020900129     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: 10.17179/excli2016-668     Document Type: Article

References (41)

1. Akhtar J, Hussain Siddiqui H, Fareed S, Aqil M. Nanomulsion as a carrier for efficient delivery of metformin. Curr Drug Deliv. 2014;11:243-52.
2. Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413-20.
3. Biçer E, Özdemir S. Interaction thermodynamics of rutin (Vitamin P) with basic L-amino acids at physiological pH: the effect of temperature on the affinity order. Russ J Electrochem. 2014;50:1058.
4. Chen H, Miao Q, Geng M, Liu J, Hu Y, Tian L, et al. Anti-tumor effect of rutin on human neuroblastoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis. Sci World J. 2013;2013:269165.
5. Chibber S, Farhan M, Hassan I, Naseem I. Novel aspect of chemophototherapy in treatment of cancer. Tumor Biol. 2012;33:701-6.
6. Couch JF. Rutin a new drug from buckwheat. In: United States Department of Agriculture (Ed.): Crops in peace and war: The yearbook of agriculture, 1950-1951 (pp 742-5). Washington, DC: U.S. Government Printing Office, 1951.
7. Couch JF, Naghski J, Krewson CF. Buckwheat as a Source of Rutin. Science. 1946;103:197-8.
8. Eccleston J. Microemulsions. In: Swarbrick J, Boylan JC (eds): Encyclopedia of pharmaceutical technology (pp 375-421). New York, NY: Marcel Dekker, 1994.
9. Fleury C, Mignotte B, Vayssière JL. Mitochondrial reactive oxygen species in cell death signaling. Biochimie. 2002;84:131-41.
10. Fraga M, Laux M, Rejane dos Santos G, Zandona B, Dos Santos Giuberti C, de Oliveira MC, et al. Evaluation of the toxicity of oligonucleotide/cationic nanoemulsion complexes on Hep G2 cells through MTT assay. Pharmazie. 2008;63:667-70.
11. Ghiasi M, Azadnia A, Arabieh M, Zahedi M. Protective effect of rutin (vitamin p) against heme oxidation: a quantum mechanical approach. Comp Theor Chem. 2012;996:28-36.
12. Grzybowski A, Pietrzak K. Albert Szent-Györgyi (1893-1986): the scientist who discovered vitamin C. Clin Dermatol. 2013;31:327-31.
13. Gupta S, Kesarla R, Omri A. Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems. ISRN Pharm. 2013;2013:848043.
14. Huang RF, Wei YJ, Inbaraj BS, Chen BH. Inhibition of colon cancer cell growth by nanoemulsion carrying gold nanoparticles and lycopene. Int J Nanomed. 2015; 10:2823-46.
15. Ikeda NE, Novak EM, Maria DA, Velosa AS, Pereira RM. Synthesis, characterization and biological evaluation of Rutin–zinc (II) flavonoid-metal complex. Chem Biol Interact. 2015;239:184-91.
16. Kaur H, Kaur G. A critical appraisal of solubility enhancement techniques of polyphenols. J Pharm. 2014; 2014:180845.
17. Krewson CF, Couch JF. Production of rutin from buckwheat. J Pharm Sci. 1950;39:163-9.
18. Kumar S, Suresh PK, Vijayababu MR, Arunkumar A, Arunakaran J. Anticancer effects of ethanolic neem leaf extract on prostate cancer cell line (PC-3). J Ethnopharmacol. 2006;105:246-50.
19. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Drug Deliv Rev. 2012; 64:175-93.
20. Lin JP, Yang JS, Lu CC, Chiang JH, Wu CL, Lin JJ, et al. Rutin inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immune response in vivo. Leuk Res. 2009;33:823-28.
21. Lin JP, Yang JS, Lin JJ, Lai KC, Lu HF, Ma CY, et al. Rutin inhibits human leukemia tumor growth in a murine xenograft model in vivo. Environ Toxicol. 2012; 27:480-4.
22. Litvinov IV, Antony L, Dalrymple SL, Becker R, Cheng L, Isaacs JT. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor. Prostate. 2006;66:1329-38.
23. Liu RH. Dietary bioactive compounds and their health implications. J Food Sci. 2013;78:18-25.
24. Louzada S, Adega F, Chaves R. Defining the sister rat mammary tumor cell lines HH-16 cl.2/1 and HH- 16.cl.4 as an in vitro cell model for Erbb2. PloS one. 2012;7(1):e29923.
25. Macedo AS, Quelhas S, Silva AM, Souto EB. Nanoemulsions for delivery of flavonoids: formulation and in vitro release of rutin as model drug. Pharm Dev Technol. 2014;19:677-80.
26. Marzouk MS, Soliman FM, Shehata IA, Rabee M, Fawzy GA. Flavonoids and biological activities of Jussiaea repens. Nat Prod Res. 2007;21:436-43.
27. Naif Abdullah Al-Dhabi NA, Arasu MV, Park CH, Park SU. An up-to-date review of rutin and its biological and pharmacological activities. EXCLI J. 2015; 14:59–63.
28. Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B, et al. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012;45:487-98.
29. Pan MH, Ho CT. Chemopreventive effects of natural dietary compounds on cancer development. Chem Soc Rev. 2008;37:2558–74.
30. Rahman A, Harwansh R, Mirza A, Hussain S, Hussain A. Oral lipid based drug delivery system: formulation, characterization and application: a review. Curr Drug Deliv. 2011;8:330-45.
31. Scalbert A, Manach C, Morand C, Rémésy C, Jiménez L. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr. 2005;45:287-306.
32. Schunck E. On the yellow colouring matters obtained from the leaves of Polygonum fagoeyrum, or common buckwheat. Mem Proc Manchester Lit Phil Soc Series 2. 1860;15:122-9.
33. Shafiq-un-Nabi S, Shakeel F, Talegaonkar S, Ali J, Baboota S, Ahuja A, et al. Formulation development and optimization using nanoemulsion technique: a technical note. AAPS Pharm Sci Tech. 2007;18:E12-7.
34. Sharma S, Ali A, Ali J, Sahni JK, Baboota S. Rutin: therapeutic potential and recent advances in drug delivery. Expert Opin Investig Drugs. 2013;22:1063-79.
35. Siddiqui S, Arshad M. Osteogenic potential of punica granatum through matrix mineralization, cell cycle progression and runx2 gene expression in primary rat osteoblasts. Daru. 2014;22:72.
36. Siddiqui S, Ahmad E, Gupta M, Rawat V, Shivnath N, Banerjee M, et al. Cissus quadrangularis Linn exerts dose‐dependent biphasic effects: osteogenic and antiproliferative, through modulating ROS, cell cycle and Runx2 gene expression in primary rat osteoblasts. Cell Prolif. 2015;48:443-54.
37. Singh AK, Chaurasiya A, Singh M, Upadhyay SC, Mukherjee R, Khar RK. Exemestane loaded self-microemulsifying drug delivery system (SMEDDS): development and optimization. AAPS Pharm Sci Tech. 2008;9:628-34.
38. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003;3:768-80.
39. Ullén A, Lennartsson L, Harmenberg U, Lennernäs B, Majumder K, Holmberg AR, et al. Prostate cancer cell lines lack amplification: overexpression of HER2. Acta Oncol. 2005;44:490-5.
40. Vargo-Gogola T, Rosen JM. Modelling breast cancer: one size does not fit all. Nat Rev Cancer. 2007;7:659-72.
41. Wang L, Dong J, Chen J, Eastoe J, Li X. Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci. 2009;330:443-8.